| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |